ANG1005 in Leptomeningeal Disease From Breast Cancer
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Brain Metastases
- HER2 Negative Breast Cancer
- Leptomeningeal Carcinomatosis
- Leptomeningeal Metastases
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: 1:1 randomization to experimental arm and comparator armMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03613181
- Collaborators
- Not Provided
- Investigators
- Study Director: Betty Lawrence Angiochem Inc